Gebruikersprofielen voor "Moors, E.H.M. "

Ellen HM Moors

Professor Sustainable Innovation
Geverifieerd e-mailadres voor uu.nl
Geciteerd door 4542

Levelling the translational gap for animal to human efficacy data

GS Ferreira, DH Veening-Griffioen, WPC Boon… - Animals, 2020 - mdpi.com
Simple Summary The value of animal research has been increasingly debated, owing to
high failure rates in drug development. A potential contributor to this situation is the lack of …

Toward responsible artificial intelligence in long-term care: a scoping review on practical approaches

DRM Lukkien, HH Nap, HP Buimer, A Peine… - The …, 2023 - academic.oup.com
Background and Objectives Artificial intelligence (AI) is widely positioned to become a key
element of intelligent technologies used in the long-term care (LTC) for older adults. The …

Towards a sustainable system of drug development

EHM Moors, AF Cohen, H Schellekens - Drug discovery today, 2014 - Elsevier
Highlights • Study of impeding factors leading to system failure in drug development. •
Overview of solution directions to repair current drug development system. • Importance of safe, …

A network of heterogeneous hydrogen bonds in GNRA tetraloops

FM Jucker, HA Heus, PF Yip, EHM Moors… - Journal of molecular …, 1996 - Elsevier
RNA hairpin loops containing a GNRA consensus sequence are the most frequently occurring
hairpins in a variety of prokaryotic and eukaryotic RNAs. These tetraloops play important …

Towards cleaner production: barriers and strategies in the base metals producing industry

EHM Moors, KF Mulder, PJ Vergragt - Journal of cleaner production, 2005 - Elsevier
The most pressing environmental problems of post-mining base metals production are solid
waste production, gaseous emissions, and a high energy use. Most of the present solutions …

Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors

L Strohm, C Hehakaya, ER Ranschaert, WPC Boon… - European …, 2020 - Springer
Objective The objective was to identify barriers and facilitators to the implementation of
artificial intelligence (AI) applications in clinical radiology in The Netherlands. Materials and …

Demand articulation in emerging technologies: intermediary user organisations as co-producers?

WPC Boon, EHM Moors, S Kuhlmann, REHM Smits - Research Policy, 2011 - Elsevier
User involvement is assumed to be beneficial to innovation processes. Intermediary user
organisations contribute to articulating societal demands for innovations. However, the learning …

Reducing post-harvest food losses through innovative collaboration: Insights from the Colombian and Mexican avocado supply chains

CA Bustos, EHM Moors - Journal of Cleaner Production, 2018 - Elsevier
Postharvest losses along food supply chains have far reaching consequences for the
environment and affect the social and economic conditions of food supply chain participants, …

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

PJK Van Meer, M Kooijman, V Brinks… - MAbs, 2013 - Taylor & Francis
The immunogenicity of biopharmaceuticals used in clinical practice remains an unsolved
challenge in drug development. Non-human primates (NHPs) are often the only relevant …

[HTML][HTML] Institutional power play in innovation systems: The case of Herceptin®

P Kukk, EHM Moors, MP Hekkert - Research Policy, 2016 - Elsevier
New technologies must be accompanied by institutional change. Innovative actors therefore
need to do institutional work or take a role as an institutional entrepreneur in order to shape …